Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current Developments in the Preclinical and Clinical use of Natural Killer T cells

BioDrugs(2022)10.1007/s40259-022-00572-4Source: DataRank Database

Current Developments in the Preclinical and Clinical use of Natural Killer T cells is a research paper published in BioDrugs (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: bronzeTopics (9)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Sasha A. Singh ORCID,Emmanuel B. Asiedu,Tonya J. Webb ORCID,Christina Kratzmeier

Live enrichment

PubMed:36525216 PMC:PMC9756707

National Institutes of Health

Grant: P30CA134274

National Institutes of Health

Grant: R25GM113262

NCI NIH HHS

Grant: T32 CA154274

National Institutes of Health

Grant: 5R25GM113262-04

UMB Postbaccalaureate Research Education Program

National Institutes of Health

Grant: 2P30CA134274-04

Protocol Specific Research

bronzeLicense: Springer Nature TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s40259-022-00572-4.pdf

publisherhttps://link.springer.com/article/10.1007/s40259-022-00572-4/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9756707

Europe_PMChttps://europepmc.org/articles/PMC9756707

Europe_PMChttps://europepmc.org/articles/PMC9756707?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansNeoplasmsNatural Killer T-Cells

Keywords

NeoplasmsHumansNatural Killer T-CellsReview Article

Sustainable Development Goals

SDG 3: 3. Good health

Current Developments in the Preclinical and Clinical use of Natural Killer T cells

FAIR Checklist

Authors (4)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)